glp 1 and inflammation reduction The anti-inflammatory feature of glucagon-like peptide-1 its based diabetes drugs—Therapeutic potential exploration in lung injury Frontiers | Anti-inflammatory effects of

Abstract Selective serotonin reuptake inhibitors (SSRIs) are the first-line treatment for major depressive disorder (MDD), yet their mechanisms of action are not fully understood and their therapeutic benefit varies among individuals

5 Cardiovascular and renal outcomes with GLP-1RA in T1D In patients with T2D, large RCT studies have shown that GLP-1RA treatment reduces the risk of cardiovascular and renal outcomes (70)

Introduction In todays image-conscious and performance-driven world, skin health is no longer a luxury it is a strategic investment in confidence and personal branding

The secondary outcome was all-cause mortality